RYVENT
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 05 Aug 2025)
What this means for you
Registered since 02 Apr 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87130283
- Registration number
- 5715976
- Mark type
- Stylized text
- Filed
- 08 Aug 2016
- Published for opposition
- 10 Jan 2017
- Registered
- 02 Apr 2019
- Attorney of record
- Timothy D. Pecsenye
Goods and services
- Class 005 — Pharmaceuticals: Prescription and non-prescription medicines, namely, tablets and liquid medicines for the treatment of allergies, seasonal allergies, perennial allergic rhinitis, and vasomotor rhinitis
Owner
- Carwin Pharmaceutical Associates, LLC, Hazlet, NJ, US
- Carwin Pharmaceutical Associates, LLC, Hazlet, NJ, US
- Carwin Pharmaceutical Associates, LLC, Hazlet, NJ, US
Prosecution history
- 05 Aug 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 05 Aug 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 05 Aug 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 01 Apr 2025 — TEAS SECTION 8 & 15 RECEIVED
- 02 Apr 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 02 Apr 2019 — REGISTERED-PRINCIPAL REGISTER
- 01 Mar 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 28 Feb 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 06 Feb 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 10 Jan 2019 — USE AMENDMENT FILED
- 05 Feb 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 10 Jan 2019 — TEAS STATEMENT OF USE RECEIVED
- 04 Sept 2018 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 25 Jul 2018 — TTAB RELEASE CASE TO TRADEMARKS
- 25 Jul 2018 — OPPOSITION TERMINATED NO. 999999